Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

Quinoline-based tracers targeting FAP show theranostic potential

Oct. 3, 2018

Optimized neuroimaging with fluorine-18-labeled SV2A PET tracers

Sep. 28, 2018

SGM-101 is safe and effective for intraoperative imaging of pancreatic ductal adenocarcinoma

Sep. 28, 2018

PET tracer for renal imaging tested in vivo

Sep. 21, 2018

First-in-human data for CCR2-targeted PET tracer [64Cu]DOTA-ECL-1i

Sep. 18, 2018

Integrin alphaVbeta6 PET tracer shows promise for assessment of interstitial lung disease

Sep. 17, 2018

Progenics reports topline phase III data on 1404 in low-grade prostate cancer

Sep. 13, 2018

Phase III study of PET imaging agent flortaucipir F 18 meets primary endpoints

Sep. 6, 2018

Telix submits CTA to begin phase III trial in Europe with TLX-250 for renal cancer imaging

Aug. 24, 2018

First patients imaged in phase II expanded access study of 68Ga-PSMA-11

Aug. 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...